Product information and disease descriptionProduct descriptionProduct information
Co-prescribed/Concomitant therapies
6 evidence topics · 5 sources
First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab
Product information and disease descriptionProduct descriptionProduct information
6 evidence topics · 5 sources